Literature DB >> 18387258

Stem and progenitor cell therapies: recent progress for spinal cord injury repair.

J Louro1, D D Pearse.   

Abstract

Mechanical trauma to the spinal cord is often accompanied by irreversible tissue damage, limited endogenous repair and permanent loss of motor, sensory and autonomic function. The implantation of exogenous cells or the stimulation of endogenous cells, to repopulate and replace or to provide a conducive environment for repair, offers a promising therapeutic direction for overcoming the multitude of obstacles facing successful recovery from spinal cord injury. Although relatively new to the scene of cell based therapies for reparative medicine, stem cells and their progenitors have been labeled as the 'cell of the future' for revolutionizing the treatment of CNS injury and neurodegenerative disorders. The following review examines the different types of stem cells and their progenitors, their utility in experimental models of spinal cord injury and explores the outstanding issues that still need to be addressed before they move towards clinical implementation.

Entities:  

Mesh:

Year:  2008        PMID: 18387258     DOI: 10.1179/174313208X284070

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  18 in total

1.  Differentiation of cryopreserved human umbilical cord blood-derived stromal cells into cells with an oligodendrocyte phenotype.

Authors:  Yong-Chun Luo; Hong-Tian Zhang; Hao-Yu Cheng; Zhi-Jun Yang; Yi-Wu Dai; Ru-Xiang Xu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-04-27       Impact factor: 2.416

2.  Alternating current electric fields of varying frequencies: effects on proliferation and differentiation of porcine neural progenitor cells.

Authors:  Ji-Hey Lim; Seth D McCullen; Jorge A Piedrahita; Elizabeth G Loboa; Natasha J Olby
Journal:  Cell Reprogram       Date:  2013-08-20       Impact factor: 1.987

3.  Induction of human umbilical Wharton's jelly-derived stem cells toward oligodendrocyte phenotype.

Authors:  Elmira Mikaeili Agah; Kazem Parivar; Mohammad Nabiuni; Mehrdad Hashemi; Masoud Soleimani
Journal:  J Mol Neurosci       Date:  2013-09-11       Impact factor: 3.444

4.  Suspension matrices for improved Schwann-cell survival after implantation into the injured rat spinal cord.

Authors:  Vivek Patel; Gravil Joseph; Amit Patel; Samik Patel; Devin Bustin; David Mawson; Luis M Tuesta; Rocio Puentes; Mousumi Ghosh; Damien D Pearse
Journal:  J Neurotrauma       Date:  2010-05       Impact factor: 5.269

5.  The use of cellular magnetic resonance imaging to track the fate of iron-labeled multipotent stromal cells after direct transplantation in a mouse model of spinal cord injury.

Authors:  Laura E Gonzalez-Lara; Xiaoyun Xu; Klara Hofstetrova; Anna Pniak; Yuhua Chen; Catherine D McFadden; Francisco M Martinez-Santiesteban; Brian K Rutt; Arthur Brown; Paula J Foster
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

6.  In vitro and in vivo magnetic resonance tracking of Sinerem-labeled human umbilical mesenchymal stromal cell-derived Schwann cells.

Authors:  Qiang Xu; Hong-Tian Zhang; Ke Liu; Jun-Hua Rao; Xiao-Ming Liu; Li Wu; Bai-Nan Xu
Journal:  Cell Mol Neurobiol       Date:  2010-12-01       Impact factor: 5.046

7.  Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury.

Authors:  Qilin Cao; Qian He; Yaping Wang; Xiaoxin Cheng; Russell M Howard; Yiping Zhang; William H DeVries; Christopher B Shields; David S K Magnuson; Xiao-Ming Xu; Dong H Kim; Scott R Whittemore
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

8.  Transplantation of neural progenitor cells in chronic spinal cord injury.

Authors:  Y Jin; J Bouyer; J S Shumsky; C Haas; I Fischer
Journal:  Neuroscience       Date:  2016-02-04       Impact factor: 3.590

Review 9.  Stem cells in human neurodegenerative disorders--time for clinical translation?

Authors:  Olle Lindvall; Zaal Kokaia
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

10.  Therapeutic effect of transplanted human Wharton's jelly stem cell-derived oligodendrocyte progenitor cells (hWJ-MSC-derived OPCs) in an animal model of multiple sclerosis.

Authors:  Elmira Mikaeili Agah; Kazem Parivar; Mohammad Taghi Joghataei
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.